Surfactin C1

Surfactin C1 is an amphiphilic biosurfactants. Surfactin C1 inhibits leukemic cell (HL-60) adhesion to human umbilical vein endothelial cells (HUVEC) . Surfactin C1 inhibits adhesion melecules expression, such as ICAM-1 and VCAM-1[1].

Product Specifications

CAS Number

[24730-31-2]

UNSPSC

12352209

Target

Integrin

Type

Reference compound

Related Pathways

Cytoskeleton

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/surfactin-c1.html

Purity

99.36

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

OC(C[C@H]1C(N[C@@H](C(N[C@H](C(OC(CC(N[C@H](C(N[C@H](C(N[C@@H](C(N[C@H](C(N1)=O)C(C)C)=O)CC(C)C)=O)CC(C)C)=O)CCC(O)=O)=O)CCCCCCCCCC(C)C)=O)CC(C)C)=O)CC(C)C)=O)=O

Molecular Formula

C53H93N7O13

Molecular Weight

1036.34

References & Citations

[1]Takahashi T, et al. Inhibition of lipopolysaccharide activity by a bacterial cyclic lipopeptide surfactin. J Antibiot (Tokyo) . 2006 Jan;59 (1) :35-43.